178 filings
Page 3 of 9
8-K
nfc0c2ll1s hszfj9f1b
25 May 22
Submission of Matters to a Vote of Security Holders
5:20pm
8-K
p5i0d1sv5k0
6 May 22
Intercept Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update
7:16am
8-K
vd5s185cps2ht
5 May 22
Entry into a Material Definitive Agreement
7:16am
8-K
pkelaey tip
2 Mar 22
Intercept Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results, Issues 2022 Financial Guidance and Provides Business Update
8:00am
8-K
4shsq hqz
9 Feb 22
Entry into a Material Definitive Agreement
4:01pm
8-K
9k3a2lhhfctp0d65ai
7 Feb 22
Other Events
4:36pm
8-K
lxtgllusqecjkrv
7 Feb 22
Other Events
4:01pm
8-K
u7kgfixa9q5 wen4wihh
31 Jan 22
Departure of Directors or Certain Officers
4:01pm
8-K
amrl26
10 Jan 22
Departure of Directors or Certain Officers
4:01pm
8-K
66h 443oelqvj4g6kaqf
20 Dec 21
Intercept Pharmaceuticals Provides Update on Phase 3 REVERSE Trial in Compensated Cirrhosis Due to NASH
8:05am
8-K
3d392me6 o9qqbu8murn
9 Dec 21
Intercept Announces Withdrawal of EMA Marketing Authorization Application for Obeticholic Acid for Advanced Liver Fibrosis Due to NASH
7:00am
8-K
jqv1j
3 Nov 21
Intercept Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update
7:16am
8-K/A
rzv7n1 00dqcagtmy2bg
22 Oct 21
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
xctyexz in
23 Aug 21
Entry into a Material Definitive Agreement
4:31pm
8-K
6easat
11 Aug 21
Intercept Pharmaceuticals Announces Convertible Notes Exchange, New Issuance and Stock Repurchase
8:08am
8-K
x9fpo04lwyhhyfvb53
29 Jul 21
Intercept Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update
7:16am
8-K
1ekoxbabm5lo
7 Jun 21
Intercept Appoints Andrew Saik as Chief Financial Officer
8:15am
8-K
qjtl8zsq ze
27 May 21
Departure of Directors or Certain Officers
4:31pm
8-K
v8gdvml1 mx60j8
26 May 21
Intercept Announces Updated Ocaliva® (obeticholic acid) U.S. Prescribing Information
5:21pm
8-K
qlzq7qts12mvw4h79
6 May 21
Intercept Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update
7:16am